Found 6 matching trials
Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma
PHASE1Laboratory studies suggest that the study drug may stop cancer cells from g...
Location
USC Norris Comprehensive Cancer Center
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
PHASE2The goal of this open-label randomized, multicenter, comparative phase II t...
Location
Institut de Cancérologie de l'Ouest
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
EARLY_PHASE1There is a growing number of patients diagnosed with gastrointestinal cance...
Location
University of Arizona Cancer Center
Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.
N/APancreatic cancer is burdened by a survival of barely 10% at 5 years. About...
Location
Multiple Locations
Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy
N/APancreatic cancer, which has a poor prognosis, is becoming increasingly com...
Status
Active Not Recruiting
Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases
PHASE2The main objective is to compare resection rates (R0 or R1) for hepatic met...
Location
Centre Val d'Aurelle